España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Athira Pharma
ATHA
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.5760
0.03
5.11%
At close: -
$0.5794
0.00340
0.59%
After Hours: Dec 20, 7:23 PM EDT
Get Report
Comment
Athira Pharma (ATHA) Forecast
News
Earnings
Athira Pharma (ATHA) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Athira Pharma (NASDAQ:ATHA) Stock
Athira Pharma Stock (NASDAQ: ATHA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Saturday, December 07, 2024
Athira Pharma Presents Preclinical Data Highl...
Benzinga Newsdesk
Friday, November 08, 2024
Althira Pharma shares are trading lower after...
Benzinga Newsdesk
Thursday, November 07, 2024
Athira Pharma Q3 EPS $(0.75) Misses $(0.69) E...
Benzinga Newsdesk
Tuesday, November 05, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Friday, November 01, 2024
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Why Charter Communications Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Thursday, October 31, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Tuesday, October 22, 2024
Athira Pharma shares are trading higher after...
Benzinga Newsdesk
Athira Pharma To Present Results From Phase 2...
Benzinga Newsdesk
Friday, October 18, 2024
Athira Pharma Receives Nasdaq Non-Compliance ...
Benzinga Newsdesk
Thursday, September 19, 2024
Robinhood To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Thursday
Avi Kapoor
Mizuho Downgrades Athira Pharma to Neutral, L...
Benzinga Newsdesk
Tuesday, September 17, 2024
Athira Pharma To Focus On Advancement Of ATH-...
Benzinga Newsdesk
Wednesday, September 04, 2024
Crude Oil Down 1%; Dollar Tree Shares Tumble After Downbeat Earnings
Avi Kapoor
JMP Securities Downgrades Athira Pharma to Ma...
Benzinga Newsdesk
BTIG Downgrades Athira Pharma to Neutral
Benzinga Newsdesk
Athira Pharma shares are trading lower after ...
Benzinga Newsdesk
US Stocks Mixed; Trade Gap Widens In July
Avi Kapoor
Athira Pharma's Alzheimer's Candidate Fails To Improve Cognition And Function In Patients With Mild/Moderate Disease, Stock Sinks
Vandana Singh
Why GitLab Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Tuesday, September 03, 2024
Athira Pharma shares are trading lower after ...
Benzinga Newsdesk
Athira Pharma Shares Resume Trade
Benzinga Newsdesk
Trading Halt: Halt status updated at 4:25:00 ...
Benzinga Newsdesk
Athira Reports Results From Phase 2/3 LIFT-AD...
Benzinga Newsdesk
Trading Halt: Halted at 4:00:11 p.m. ET - Tra...
Benzinga Newsdesk
Monday, August 19, 2024
Athira Pharma shares are trading higher after...
Benzinga Newsdesk
Rodman & Renshaw Initiates Coverage On Athira...
Benzinga Newsdesk
Thursday, August 01, 2024
Athira Pharma Q2 EPS $(0.70) Beats $(0.74) Es...
Benzinga Newsdesk
Wednesday, July 31, 2024
Athira Pharma To Present Preclinical Data Dem...
Benzinga Newsdesk
Wednesday, July 10, 2024
Athira Completes Dosing in Alzheimer's Study, Stock Up
Zacks
Thursday, June 20, 2024
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Tuesday, June 11, 2024
Athira Pharma Advances ALS Drug with Successf...
Benzinga Newsdesk
Monday, June 03, 2024
Athira Pharma To Be Issued US Patent For "Met...
Benzinga Newsdesk
Thursday, May 16, 2024
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Athira Pharma shares are trading higher after...
Benzinga Newsdesk
Wednesday, May 15, 2024
Athira Pharma Q1 2024 GAAP EPS $(0.69) Beats ...
Benzinga Newsdesk
Thursday, April 11, 2024
Athira Pharma Announces Publication of Precli...
Benzinga Newsdesk
Wednesday, March 27, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Friday, March 08, 2024
Athira Pharma Presents Clinical and Preclinic...
Benzinga Newsdesk
Thursday, February 08, 2024
Athira Pharma Announces Publication In Fronti...
Benzinga Newsdesk
Monday, January 08, 2024
Athira Pharma Provides 2024 Clinical Pipeline...
Benzinga Newsdesk
Wednesday, January 03, 2024
Athira Pharma Has Completed Enrollment In The...
Benzinga Newsdesk
Tuesday, January 02, 2024
$1.5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
Avi Kapoor
Tuesday, December 12, 2023
Athira Pharma Announces Results from SHAPE Ph...
Benzinga Newsdesk
Tuesday, November 28, 2023
Athira Pharma Announced That A Symposium Pres...
Benzinga Newsdesk
Wednesday, November 15, 2023
Athira Pharma Presents Preclinical Data Highl...
Benzinga Newsdesk
Thursday, November 09, 2023
Athira Pharma Q3 EPS $(0.87) Misses $(0.81) E...
Benzinga Newsdesk
Thursday, October 05, 2023
Athira Pharma Presents Preclinical Data Furth...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch